Page 6 - John Simard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(1) XBiotech's New Drug to Enter Clinical Studies in Combination Therapy for Pancreatic Cancer AUSTIN, Texas, April 19, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that the FDA has granted permission to commence clinical trials with its novel drug candidate for treating patients with pancreatic cancer. From 1992 to 2018 the death rate from pancreatic cancer steadily increased in the USA. It is now predicted that pancreatic cancer will claim 48,220 lives and be the 3 rd leading cause of cancer death in the USA in 2021 (National Cancer Institute's Surveillance, Epidemiology...

XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders who specialize in cerebrovascular diseases including ischemic stroke, which is the third leading cause of death and second leading cause of disability in the world. The CMAB...

XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy AUSTIN, Texas, Jan. 19, 2021 — XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders who specialize in cerebrovascular diseases including ischemic stroke, which is the third leading cause of death and second leading cause of disability in the world. The CMAB is chaired by Clay Johnston, M.D., Ph.D., ...